Novel Rho-Kinase-II Inhibitor with Vasodilatory Activity

Specific Ligand for Stem Loop 3 Ribonucleic Acid of the Packaging Signal Ψ of Human Immunodeficiency Virus-1

Novel substrate of ABCG2

Novel Inhibitor of the p53-mdm2 Interaction, Activating p53-Dependent Transcription in mdm2-Overexpressing Cells

Novel Rho-Kinase-II Inhibitor with Vasodilatory Activity

Novel potent gonist of Human G Protein-Coupled Receptor-35 (hGPR35) (EC50 8 nM)

Novel inhibitor of Chk1 pathway in 5-FU-resistant CRC bulk and stem cell populations

Novel selective inhibitor of TET1 transcription and 5-hydroxymethylcytosine (5hmC) modification, effectively inhibiting cell viability in AML with high expression of TET1

Potent inhibitor of the AcrAB-TolC efflux pump in Escherichia coli, potentiating the antibacterial activities of novobiocin and erythromycin upon binding to the membrane fusion protein AcrA

Novel potent Mycobacterium tuberculosis DHFR inhibitor

Selective potentiator at GluN1/GluN2C and GluN1/GluN2D receptors

DT-diaphorase inhibitor

Novel Rho-Kinase-II Inhibitor with Vasodilatory Activity

Potent apoptosis inducer in pancreatic cancer cells

Novel potent inhibitor of Huntington's disease (HD) pathogenesis via targeting CAG repeats RNA and Poly Q protein

Novel antagonist of the Grb7 SH2 domain; Antitumor Agent

Novel specific inhibitor of EGF receptor autophosphorylation and cell proliferation in HeLa cells by disrupting allosteric activation of EGF-stimulated dimer

Novel antagonist of the Grb7 SH2 domain; Antitumor Agent

Novel potent SHP2 Inhibitor with Anti-Proliferative Activity in Breast Cancer Cell Lines

Novel non-peptide disruptor of IKKß/NEMO complex

Novel efflux pump inhibitor (EPI)

Novel activator of lanthionine synthetase C-like 2 (LANCL2), down-modulating pulmonary inflammation through the downregulation of TNF-α and MCP-1 and reduction in the infiltration of neutrophils, accelerating recovery and inducing IL-10-mediated regulator